Reactions 1680, p185 - 2 Dec 2017 Various toxicities: 2 case reports In a retrospective, single-center study of 14 patients, 2 patients [ages not stated, not all sexes stated] were described. Out of whom, one patient developed grade 2 weight loss and other one female developed fever, lymphopenia, anaemia, thoracic pain, hypertension, pulmonary oedema and renal insufficiency along with cardiac arrest during treatment with Both patients had a history of malignant pheochromocytoma/paraganglioma (MPPGL) and they received interferon-α-2b for its treatment. They received SC interferon-α-2b injection 1.5 MU, thrice in a week, 28 day cycle. In one patient interferon-α-2b dose was reduced as the patient developed grade 2 weight loss. The other patient (female) was admitted to the ICU one month after the therapy discontinuation due to fever, lymphopenia and anaemia without any evidence of infectious disease. In addition to this, she complained of hypertension, pulmonary oedema, thoracic pain and renal insufficiency. Thereafter her condition exacerbated and she died because of cardiac arrest. Disease progression was also hypothesised as a cause of death [duration of treatment to reactions onsets not stated; outcome of other ADRs prior to death not stated]. Author comment: "The [interferon]-alpha dose was reduced in four patients: because of asthenia in three patients (one grade 2 and two grade 3) and because of grade 2 weight loss in one patient." "One patient was admitted to the intensive care unit 1 month after [interferon]-alpha discontinuation because of fever, lymphopenia, and anemia with no evidence of infectious disease and normal blood pressure." Hadoux J, et al. Interferon-alpha Treatment for Disease Control in Metastatic Pheochromocytoma/Paraganglioma Patients. Hormones and Cancer 8: 330-337, No. 5, Dec 2017. Available from: URL: http://doi.org/10.1007/s12672-017-0303-8 - France 803285003 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680
Reactions Weekly – Springer Journals
Published: Dec 2, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera